Metabolomic biomarkers could be molecular clocks in timing stroke onset

Metabolomic biomarkers could be molecular clocks in timing stroke onset

Abstract The preferred treatment for acute ischaemic stroke (AIS) is intravenous thrombolysis (IVT) administered within 4.5 hours (h) of symptom onset. This study aimed to identify metabolomic biomarkers for distinguishing AIS patients within 4.5 h of symptom onset, addressing the often exclusion of...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianyun Li, Xiaodan Zhang, Yilin Zhang, Rex Pui Kin Lam, Yulan Jin, Chengcheng Ji, Weinv Fan, Timothy Hudson Rainer
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Biomarkers
Intravenous thrombolysis
Machine learning
Metabolomics
Stroke
Online Access:https://doi.org/10.1038/s41598-025-05334-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-05334-0

Similar Items